| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/17/2009 | CA2348380C Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
| 02/17/2009 | CA2299464C Controlled release pharmaceutical compositions containing tiagabine |
| 02/12/2009 | WO2009021129A1 Sulfamide derivative useful for the treatment of epilepsy |
| 02/12/2009 | WO2009020579A1 Gamma secretase modulators |
| 02/12/2009 | WO2009020578A1 Alpha2c adrenoreceptor agonists |
| 02/12/2009 | WO2009020419A1 New treatment for chemical substance addiction |
| 02/12/2009 | WO2009020304A1 A composition comprising an extract of scrophularia radix for treating and preventing cognitive impairment involved disease |
| 02/12/2009 | WO2009020140A1 Adamantylurea derivative |
| 02/12/2009 | WO2009020137A1 Aminopyrazole amide derivative |
| 02/12/2009 | WO2009020058A1 Drug delivery system toward demyelinating lesion and biochemical marker of demyelinating lesion |
| 02/12/2009 | WO2009019815A1 Novel γ-secretase inhibitor |
| 02/12/2009 | WO2009019503A2 P2x7 antagonists for use in the treatment of mood disorders |
| 02/12/2009 | WO2009019472A1 1, 2, 4 -triazole derivatives as serotonergic modulators |
| 02/12/2009 | WO2009019281A1 Benzoisoindole derivatives and their use as ep4 receptor agonists for the treatment of pain |
| 02/12/2009 | WO2009019278A1 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/12/2009 | WO2009019133A1 Trazodone and trazodone hydrochloride in purified form |
| 02/12/2009 | WO2009019032A2 Novel method for screening brain-active compounds |
| 02/12/2009 | WO2009018959A1 Salts of tramadol and naproxen and their crystal forms in the treatment of pain |
| 02/12/2009 | WO2009018824A1 Use of a composition comprising at least one beta-blocker for the treatment of sleep disorders |
| 02/12/2009 | WO2009018748A1 Use of 2,5-dihydroxyphenymethanol or its derivates in preparing the medicine or functional food for treating or preventing depression |
| 02/12/2009 | WO2009018747A1 The application of 3, 5-dihydroxytoluene or derivatives thereof in the preparation of medicine and functional for treating or preventing depression. |
| 02/12/2009 | WO2009018625A1 Treatment of prion protein related diseases |
| 02/12/2009 | WO2008144061A3 Novel combinations comprising a phosphodiesterase-5 inhibitor and their use |
| 02/12/2009 | WO2008135527A3 Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders |
| 02/12/2009 | WO2008126932A3 Epigenetical regulation of brain plasticity |
| 02/12/2009 | WO2008107480A8 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators |
| 02/12/2009 | WO2008104386A3 Method for the treatment of amyloidoses |
| 02/12/2009 | WO2008071605A3 Methods of treating inflammatory diseases |
| 02/12/2009 | WO2008057933A3 Methods of treating neuropathic pain by modulation of glycogenolysis or glycolysis pathways |
| 02/12/2009 | WO2008033460A3 Treating pain, diabetes, and lipid metabolism disorders |
| 02/12/2009 | US20090042993 Identification of novel post-translational protein modifications |
| 02/12/2009 | US20090042982 Method for treating neurological disorders using acetone derivatives |
| 02/12/2009 | US20090042980 Neuroprotective compositions and methods |
| 02/12/2009 | US20090042968 Therapeutic compositions for intranasal administration of ketorolac |
| 02/12/2009 | US20090042964 Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as beta-secretase inhibitors |
| 02/12/2009 | US20090042956 Compositions and methods of using (r)-pramipexole |
| 02/12/2009 | US20090042953 IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES |
| 02/12/2009 | US20090042945 Benzo[d]isoxazol-3-yl-amine Compounds and Their Use as Vanilloid Receptor Ligands |
| 02/12/2009 | US20090042943 Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors |
| 02/12/2009 | US20090042937 Nitroxides for use in treating or preventing amyloid-related diseases |
| 02/12/2009 | US20090042934 Sulfonyl-Quinoline Derivatives |
| 02/12/2009 | US20090042933 Derivatives of 4-(2-amino -1-hydroxyethyl)phenol as agonists of the Beta2 adrenergic receptor |
| 02/12/2009 | US20090042931 Tricyclic Angiotensin II Agonists |
| 02/12/2009 | US20090042928 Modulators of muscarinic receptors |
| 02/12/2009 | US20090042912 DIPHENYLIMIDAZOLYL COMPOUNDS AS INHIBITORS OF beta-SECRETASE |
| 02/12/2009 | US20090042908 Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation |
| 02/12/2009 | US20090042907 Bicyclic aromatic sulfinyl derivatives |
| 02/12/2009 | US20090042904 Substituted Phenly-Piperazine Compounds, Their Preparation And Use In Medicaments |
| 02/12/2009 | US20090042902 Hydroxyiminopiperazine compounds, used as vanilloid receptor antagonists; analgesics |
| 02/12/2009 | US20090042899 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 02/12/2009 | US20090042897 Chemical Compounds |
| 02/12/2009 | US20090042896 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/12/2009 | US20090042895 Antidepressant Piperidine Derivatives of Heterocycle-Fused Benzodioxans |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042874 Antidepressant heteroaryl derivatives of heterocycle-fused benzodioxans |
| 02/12/2009 | US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 02/12/2009 | US20090042871 delta-opioid receptor agonists as analgesics having reduced side effects and antagonists as immunosuppressants, antiinflammatory agents, neurological, psychiatric , urological and reproductive conditions; N-{2-[10-(8-Allyl-8-aza-bicyclo[3.2.1]oct-3-yl)-10H-phenothiazine-3-yl]-phenyl}-acetamide |
| 02/12/2009 | US20090042867 Compounds for the treatment of alzheimer's disease |
| 02/12/2009 | US20090042862 Novel compounds |
| 02/12/2009 | US20090042861 Prophylactic or Therapeutic Agent for Depression or Anxiety Disorder |
| 02/12/2009 | US20090042856 Pyridazinone derivatives used for the treatment of pain |
| 02/12/2009 | US20090042855 BENZAMIDE mGluR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME |
| 02/12/2009 | US20090042854 Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists |
| 02/12/2009 | US20090042851 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors |
| 02/12/2009 | US20090042828 Nucleic acid with 1st sequence encoding antisense RNAi specific for targeting regions of copper zinc superoxide dismutase that cause inherited amyotrophic lateral sclerosis, and a 2nd sequence encoding a RNAi resistant replacement gene with silent mutations encoding messenger RNA resistant to cleavage |
| 02/12/2009 | US20090042827 Antiviral oligonucleotides targeting hbv |
| 02/12/2009 | US20090042818 Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists |
| 02/12/2009 | US20090042817 Use of an Active Ingredient Combination That Contains Hydroxystilbene for Preventing and/or Treating Diseases |
| 02/12/2009 | US20090042807 By reducing macrophage NO production through administration of one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides; inhibition of neucrosis factor kappa Beta mediated inflammatory cytokine release |
| 02/12/2009 | US20090042804 Novel peptide amphiphiles having improved solubility and methods of using same |
| 02/12/2009 | US20090042797 Gamma-heregulin |
| 02/12/2009 | US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use |
| 02/12/2009 | US20090042789 Method for Improving Symptom of Mood Disorder |
| 02/12/2009 | US20090042783 Apo e analogs and methods for their use |
| 02/12/2009 | US20090042270 Activatable recombinant neurotoxins |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090041877 Composition comprising growth factor of xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 02/12/2009 | US20090041865 Extract of the Family Dioscoreaceae and Composition for Preventing or Treating Peripheral Neuropathy Comprising the Same |
| 02/12/2009 | US20090041844 Modified Release Formulation |
| 02/12/2009 | US20090041800 Methods for Treating Dependence |
| 02/12/2009 | US20090041753 Cytokine signaling |
| 02/12/2009 | US20090041750 Treatment of spongiform encephalopathy by increased hydrogen peroxide degradation |
| 02/12/2009 | US20090041745 Modulators of paraptosis and related methods |
| 02/12/2009 | US20090041728 Proteoglycan Degrading Mutants for the Treatment of CNS |
| 02/12/2009 | US20090041722 Indole indane amide compounds useful as cb2 agonists and method |
| 02/12/2009 | US20090041667 Treatment of Depressive Disorders |
| 02/12/2009 | US20090041665 Method for gene delivery to neuronal cells |
| 02/12/2009 | CA2830727A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 02/12/2009 | CA2696253A1 Sulfamide derivative useful for the treatment of epilepsy |
| 02/12/2009 | CA2695877A1 Novel .gamma.-secretase inhibitor |
| 02/12/2009 | CA2695864A1 Gamma secretase modulators |
| 02/12/2009 | CA2695812A1 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/12/2009 | CA2695621A1 Pyridine carboxamide orexin receptor antagonists |
| 02/12/2009 | CA2695437A1 Aminopyrazole amide derivative |
| 02/12/2009 | CA2695372A1 Methods for treating dependence |
| 02/12/2009 | CA2694881A1 The application of 5-methyl-1,3-benzenediol or derivatives thereof in the preparation of medicines and functional foods for treatment or prevention of depression |
| 02/12/2009 | CA2694434A1 Treatment of prion protein related diseases |
| 02/12/2009 | CA2693095A1 Trazodone and trazodone hydrochloride in purified form |